Skip to main content

Advertisement

Log in

Opioids in pain management of blood-related malignancies

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Opioids are basic analgesics used in the treatment of moderate to severe pain in patients affected by blood-related malignancies. They should be sequentially administered according to the World Health Organisation scale for cancer pain. Initial treatment and titration with opioids should be based on immediate-release preparations, to be administered at appropriate intervals in order to relieve pain and to satisfy the individual opioid requirement. Once a relatively good pain control has been achieved, a slow release formulation at equivalent doses can be given. Most patients can be adequately managed using oral formulation opioids. However, a small group, such as those presenting severe mucositis or requiring a rapid pain relief, should be managed by intravenous continuous infusion and/or by a patient-controlled analgesia system; while for patients in the community, there are distinct advantages to using the subcutaneous route. Other available routes of administration for opioids, can be used in selected circumstances, including rectal, transdermal, epidural, intrathecal and intramuscular. The invasive neuraxial route has a very limited role in patients with haematological malignancies, given the high risk of infection and bleeding. Through a close observation and a careful management, opioid-related side effects can be effectively prevented and treated. This article reviews the principles of opioid therapy and how opioids can be adapted for patients with pain due to haematological malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Niscola P, Arcuri E, Giovannini M et al (2004) Pain syndromes in haematological malignancies: an overview. Hematol J 5(4):293–303

    Article  PubMed  Google Scholar 

  2. Niscola P, Cartoni C, Arcuri E et al (2000) Epidemiologia e fisiopatogenesi del dolore nelle neoplasie ematologiche in fase avanzata. La Rivista Italiana di Cure Palliative (RICP) 2(3):157–161 (Italian)

    Google Scholar 

  3. Vanhelleputte P, Nijs K, Delforge M, Evers G, Vanderschueren S (2003) Pain during bone marrow aspiration: prevalence and prevention. J Pain Symptom Manage 26(3):860–866 Sep

    Article  PubMed  Google Scholar 

  4. Wolanskyj AP, Schroeder G, Wilson PR, Habermann TM, Inwards DJ, Witzig TE (2000) A randomized, placebo-controlled study of outpatient premedication for bone marrow biopsy in adults with lymphoma. Clin Lymphoma 1(2):154–157 Sep

    Article  PubMed  CAS  Google Scholar 

  5. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8(1):33–39 Jan

    PubMed  CAS  Google Scholar 

  6. Holdsworth MT, Raisch DW, Winter SS et al (2003) Pain and distress from bone marrow aspirations and lumbar punctures. Ann Pharmacother 37(1):17–22 Jan

    Article  PubMed  CAS  Google Scholar 

  7. Chordas C (2001) Post-dural puncture headache and other complications after lumbar puncture. J Pediatr Oncol Nurs 18(6):244–259 Nov–Dec

    Article  PubMed  CAS  Google Scholar 

  8. Weng HR, Cordella JV, Dougherty PM (2003) Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103(1–2):131–138 May

    Article  PubMed  CAS  Google Scholar 

  9. Pederson C, Parran L (1999) Pain and distress in adults and children undergoing peripheral blood stem cell or bone marrow transplant. Oncol Nurs Forum 26(3):575–582 Apr

    PubMed  CAS  Google Scholar 

  10. Cella D, Pulliam J, Fuchs H et al (2003) Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy. Cancer 98(2):406–412 Jul 15

    Article  PubMed  Google Scholar 

  11. Abbas AA, Baker DL, Felimban KS, Husain AH (2004) Musculoskeletal and radiological manifestations of childhood acute leukaemia: a clinical review. Haema 7(4):448–455

    Google Scholar 

  12. Aricò M, Boccalatte MFP, Silvestri D et al (2003) Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88:747–753

    PubMed  Google Scholar 

  13. Niscola P, Scaramucci L, Giovannini M et al (2005) Palliative care in malignant hematology: an overview. Haema 8(2):297–315

    Google Scholar 

  14. Giovannini M, Cartoni C, Cedrone M et al (1997) Chemioterapia palliativa in pazienti con neoplasie ematologiche in fase avanzata di malattia: esperienza dell’Unità di Cure domiciliari “Romail” presso l’Istituto d’Ematologia dell’Università “La Sapienza” di Roma. (Abstract). Paper presented at the Eighth Congress of the Società Italiana di Cure Palliative (SICP), Genoa (Italian)

  15. No authors listed (1986) World Health Organization. Cancer pain relief. World Health Organization, Geneva

  16. Inturrisi CE (2002) Clinical pharmacology of opioids for pain. Clin J Pain 18(4 Suppl):S3–S13 Jul–Aug

    Article  PubMed  Google Scholar 

  17. Kalyuzhny AE (2003) Immunohistochemical localization of mu-, delta- and kappa-opioid receptors within the antinociceptive brainstem circuits. Methods Mol Med 84:79–93

    PubMed  CAS  Google Scholar 

  18. Leppert W, Luczak J (2005) The role of tramadol in cancer pain treatment—a review. Support Care Cancer 13(1):5–17 Jan

    Article  PubMed  Google Scholar 

  19. Grond S, Sablotzki A (2004) Clinical pharmacology of tramadol. Clin Pharmacokinet 43(13):879–923

    Article  PubMed  CAS  Google Scholar 

  20. McClellan K, Scott LJ (2003) Tramadol/paracetamol. Drugs 63(11):1079–1086

    Article  PubMed  CAS  Google Scholar 

  21. Mercadante S, Arcuri E, Fusco F, Tirelli W, Villari P, Bussolino C, Campa T, De Conno F, Ripamonti C (2005) Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer 13(9):702–707 Sep

    Article  PubMed  Google Scholar 

  22. Duhmke RM, Cornblath DD, Hollingshead JR (2004) Tramadol for neuropathic pain. Cochrane Database Syst Rev (2):CD003726

    PubMed  Google Scholar 

  23. Boureau F, Legallicier P, Kabir-Ahmadi M (2003) Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 104(1–2):323–331 Jul

    Article  PubMed  CAS  Google Scholar 

  24. Cossmann M, Kohnen C, Langford R, McCartney C (1997) Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance. Drugs 53(Suppl 2):50–62

    Article  PubMed  Google Scholar 

  25. No authors listed (2005) Tramadol as an NSAID alternative. Med Lett Drugs Ther 47(1202):13 Feb 14

    Google Scholar 

  26. Evans HC, Easthope SE (2003) Transdermal buprenorphine. Drugs 63(19):1999–2010

    Article  PubMed  CAS  Google Scholar 

  27. Schriek P (2004) Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases. Support Care Cancer 12(12):882–884 Dec

    Article  PubMed  Google Scholar 

  28. Donnelly S, Davis MP, Walsh D, Naughton M; World Health Organization (2002) Morphine in cancer pain management: a practical guide. Support Care Cancer 10(1):13–35 Jan

    Article  PubMed  Google Scholar 

  29. Wiffen PJ, Edwards JE, Barden J, McQuay HJ (2003) Oral morphine for cancer pain. Cochrane Database Syst Rev (4):CD003868

    PubMed  Google Scholar 

  30. Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V; Expert Working Group of the Research Network of the European Association for Palliative Care (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5):587–593 Mar 2

    Article  PubMed  CAS  Google Scholar 

  31. Mercadante S, Villari P, Ferrera P, Casuccio A, Fulfaro F (2002) Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer 95(1):203–208 Jul 1

    Article  PubMed  CAS  Google Scholar 

  32. Harris JT, Suresh Kumar K, Rajagopal MR (2003) Intravenous morphine for rapid control of severe cancer pain. Palliat Med 17(3):248–256 Apr

    Article  PubMed  CAS  Google Scholar 

  33. Mercadante S, Villari P, Ferrera P, Casuccio A, Fulfaro F (2002) Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer 95(1):203–208 Jul 1

    Article  PubMed  CAS  Google Scholar 

  34. Moolenaar F, Meijler WJ, Frijlink HW, Visser J, Proost JH (2000) Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain. Eur J Clin Pharmacol 56(3):219–223 Jun

    Article  PubMed  CAS  Google Scholar 

  35. Engelhardt T, Crawford M (2001) Sublingual morphine may be a suitable alternative for pain control in children in the postoperative period. Paediatr Anaesth 11(1):81–83 Jan

    Article  PubMed  CAS  Google Scholar 

  36. Illum L, Watts P, Fisher AN, Hinchcliffe M, Norbury H, Jabbal-Gill I, Nankervis R, Davis SS (2002) Intranasal delivery of morphine. J Pharmacol Exp Ther 301(1):391–400 Apr

    Article  PubMed  CAS  Google Scholar 

  37. Hagen NA, Thirlwell M, Eisenhoffer J, Quigley P, Harsanyi Z, Darke A (2005) Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain. J Pain Symptom Manage 29(1):80–90 Jan

    Article  PubMed  CAS  Google Scholar 

  38. Sear JW (1998) Recent advances and developments in the clinical use of i.v. opioids during the peroperative period. Br J Anaesth 81(1):38–50 Jul

    PubMed  CAS  Google Scholar 

  39. Murphy EJ (2005) Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 33(3):311–322 Jun

    PubMed  CAS  Google Scholar 

  40. Pillitteri LC, Clark RE (1998) Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 22(5):495–498 Sep

    Article  PubMed  CAS  Google Scholar 

  41. Gossop M, Keaney F, Sharma P, Jacjson M (2005) The unique role of diamorphine in British medical practice: a survey of general practitioners and hospital doctors. Eur Addict Res 11(2):76–82

    Article  PubMed  Google Scholar 

  42. Sarhill N, Walsh D, Nelson KA (2001) Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer 9(2):84–96 Mar

    Article  PubMed  CAS  Google Scholar 

  43. Levy MH (2001) Advancement of opioid analgesia with controlled-release oxycodone. Eur J Pain 5(Suppl A):113–116

    Article  PubMed  CAS  Google Scholar 

  44. Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I (1998) Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 16(10):3222–3229 Oct

    PubMed  CAS  Google Scholar 

  45. No authors listed (2003) Oral oxycodone: new preparation. No better than oral morphine. Prescr Int 12(65):83–84 Jun

    Google Scholar 

  46. Jeal W, Benfield P (1997) Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 53(1):109–138 Jan

    Article  PubMed  CAS  Google Scholar 

  47. Gourlay GK (2001) Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2(3):165–172 Mar

    Article  PubMed  CAS  Google Scholar 

  48. Payne R, Coluzzi P, Hart L et al (2001) Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage 22(1):575–583 Jul

    Article  PubMed  CAS  Google Scholar 

  49. Mercadante S (1997) Methadone in cancer pain. Eur J Pain 1(2):77–83

    Article  PubMed  CAS  Google Scholar 

  50. Bruera E, Palmer JL, Bosnjak S et al (2004) Methadone vs morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol 22(1):185–192 Jan 1

    Article  PubMed  CAS  Google Scholar 

  51. Mercadante S, Casuccio A, Fulfaro F et al (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19(11):2898–2904 Jun 1

    PubMed  CAS  Google Scholar 

  52. Rowbotham MC, Twilling L, Davies PS et al (2003) Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348(13):1223–1232 Mar 27

    Article  PubMed  CAS  Google Scholar 

  53. O’Connor AB, Lang VJ, Quill TE (2005) Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med 118:885–889

    Article  PubMed  Google Scholar 

  54. Seifert CF, Kennedy S (2004) Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy 24(6):776–783 Jun

    Article  PubMed  CAS  Google Scholar 

  55. Thompson DR (2001) Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol 96(4):1266–1272 Apr

    Article  PubMed  CAS  Google Scholar 

  56. Stevens Rom A, Ghazi Salim M (2000) Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control 7(2):132–141

    PubMed  Google Scholar 

  57. Anderson SL, Shreve ST (2004) Continuous subcutaneous infusion of opiates at end-of-life. Ann Pharmacother 38(6):1015–1023 Jun

    Article  PubMed  CAS  Google Scholar 

  58. Weinberg DS, Inturrisi CE, Reidenberg B et al (1988) Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 44:335–342

    Article  PubMed  CAS  Google Scholar 

  59. Burza M, Ginobbi P, Fusco G et al (1998) Transdermal route as an alternative to oral administration of opioids in cancer pain. Clin Ter 149(4):277–280 Jul–Aug

    PubMed  CAS  Google Scholar 

  60. Skaer TL (2004) Practice guidelines for transdermal opioids in malignant pain. Drugs 64(23):2629–2638

    Article  PubMed  CAS  Google Scholar 

  61. Brant JM (2001) Opioid equianalgesic conversion: the right dose. Clin J Oncol Nurs 5(4):163–165 Jul–Aug

    PubMed  CAS  Google Scholar 

  62. Mercadante S, Villari P, Ferrera P, Casuccio A, Fulfaro F (2002) Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer 95(1):203–208 Jul 1

    Article  PubMed  CAS  Google Scholar 

  63. Citron ML, Johnson-Early A, Boyer M et al (1986) Patient-controlled analgesia for severe cancer pain. Arch Intern Med 146:734–736

    Article  PubMed  CAS  Google Scholar 

  64. Ferrell BR, Nash CC, Warfield C (1992) The role of patient-controlled analgesia in the management of cancer pain. J Pain Symptom Manage 7:149–154

    Article  PubMed  CAS  Google Scholar 

  65. Hill HF, Chapman CR, Kornell JA et al (1990) Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain 40(2):121–129 Feb

    Article  PubMed  CAS  Google Scholar 

  66. Dunbar PJ, Buckley P, Gavrin JR, Sanders JE, Chapman CR (1995) Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant. J Pain Symptom Manage 10(8):604–611 Nov

    Article  PubMed  CAS  Google Scholar 

  67. Coda BA, O’Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD (1997) Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 72(3):333–346 Sep

    Article  PubMed  CAS  Google Scholar 

  68. Chapman CR, Donaldson GW, Jacobson RC, Hautman B (1997) Differences among patients in opioid self-administration during bone marrow transplantation. Pain 71(3):213–223 Jul

    Article  PubMed  CAS  Google Scholar 

  69. Caraceni A, Cherny N, Fainsinger R et al (2002) Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage 23(3):239–255 Mar

    Article  PubMed  Google Scholar 

  70. Twycross R, Harcourt J, Bergl S (1996) A survey of pain in patients with advanced cancer. J Pain Symptom Manage 12:273–282

    Article  PubMed  CAS  Google Scholar 

  71. Davis MP, Walsh D, Lagman R, LeGrand SB (2005) Controversies in pharmacotherapy of pain management. Lancet Oncol 6(9):696–704 Sep

    Article  PubMed  CAS  Google Scholar 

  72. Mercadante S, Arcuri E (1998) Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev 24(6):425–432 Dec

    Article  PubMed  CAS  Google Scholar 

  73. Mercadante S, Radbruch L, Caraceni A et al (2002) Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94(3):832–839 Feb 1

    Article  PubMed  Google Scholar 

  74. Mercadante S, Villari P, Ferrera P, Bianchi M, Casuccio A (2004) Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage 27(4):352–359 Apr

    Article  PubMed  CAS  Google Scholar 

  75. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V; Expert Working Group of the European Association of Palliative Care Network (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19(9):2542–2554 May 1

    PubMed  CAS  Google Scholar 

  76. Mercadante S, Arcuri E (2004) Opioids and renal function. J Pain 5(1):2–19 Feb

    Article  PubMed  CAS  Google Scholar 

  77. Ballantyne JC, Mao J (2003) Opioid therapy for chronic pain. N Engl J Med 349:1943–1953

    Article  PubMed  CAS  Google Scholar 

  78. Staats PS, Markowitz J, Schein J (2004) Incidence of constipation associated with long-acting opioid therapy: a comparative study. South Med J 97(2):129–134 Feb

    Article  PubMed  Google Scholar 

  79. Mercadante S (1999) Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86(9):1856–1866 Nov 1

    Article  PubMed  CAS  Google Scholar 

  80. Mercadante S (2004) Opioid combination for cancer pain. Br J Cancer 90(10):2049 May 17

    Article  PubMed  CAS  Google Scholar 

  81. Mach DB, Rogers SD, Sabino MC et al (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113(1):155–166

    Article  PubMed  CAS  Google Scholar 

  82. Samad TA, Moore KA, Sapirstein A et al (2001) Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410(6827):471–475 Mar 22

    Article  PubMed  CAS  Google Scholar 

  83. Ma W, Eisenach JC (2002) Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 15(6):1037–1047 Mar

    Article  PubMed  Google Scholar 

  84. Ito S, Okuda-Ashitaka E, Minami T (2001) Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 41(4):299–332 Dec

    Article  PubMed  CAS  Google Scholar 

  85. Banati RB (2002) Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? J Physiol Paris 96(3–4):289–299 Apr–Jun

    Article  PubMed  Google Scholar 

  86. Clohisy DR, Mantyh PW (2003) Bone cancer pain. Cancer 97(3 Suppl):866–873 Feb 1

    Article  PubMed  Google Scholar 

  87. Sabino MA, Luger NM, Mach DB, Rogers SD et al (2003) Different tumors in bone each gives rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system. Int J Cancer 104(5):550–558 May 1

    Article  PubMed  CAS  Google Scholar 

  88. Berenson JR (2002) Advances in the biology and treatment of myeloma bone disease. Semin Oncol 29(6 Suppl 17):11–16 Dec

    Article  PubMed  CAS  Google Scholar 

  89. Pearse RN, Sordillo EM, Yaccoby S et al (2001) Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A 98(20):11581–11586 Sep 25

    Article  PubMed  CAS  Google Scholar 

  90. Yaccoby S, Pearse RN, Johnson CL et al (2002) Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity. Br J Haematol 116(2):278–290 Feb

    Article  PubMed  Google Scholar 

  91. Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69(1–2):1–18 Jan

    Article  PubMed  CAS  Google Scholar 

  92. Ripamonti C, Fulfaro F (2000) Malignant bone pain: pathophysiology and treatments. Curr Rev Pain 4(3):187–196

    PubMed  CAS  Google Scholar 

  93. Strupp C, Sudhoff T, Germing U, Hunerliturkoglu A, Schneider P, Niederste-Hollenberg A, Heyll A, Aul C (2000) Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep 7(3):659–661 May–Jun

    PubMed  CAS  Google Scholar 

  94. Demarosi F, Lodi G, Soligo D, Sardella A, Volpe AD, Carrassi A, Eliliers GL (2004) Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 33(12):1247–1251 Jun

    Article  PubMed  CAS  Google Scholar 

  95. Nosari A, Anghilieri M, Cozzi P et al (2002) Transdremal fentanyl is useful in chemotherapy-associated mucositis. Proceedings of the forty-fourth annual meeting of the American Society of Hematology, Pennsylvania: American Society of Hematology. (Abstract) Blood 100, 11(Suppl, part 1):387b

    Google Scholar 

  96. Scaramucci L, Bongarzoni V, Niscola P et al (2002) Neuropathy as dominant picture in Primary Amyloidosis: report of a case with severe clinical course. Proceedings of the seventh annual meeting of the European Haematology Association. Florence (Italy): European Haematology Association. Haematology J 3(Suppl 1):418

    Google Scholar 

  97. Ventafridda V, Bianchi M, Ripamonti C et al (1990) Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain 43:155–162

    Article  PubMed  CAS  Google Scholar 

  98. Backonja M, Glanzman RL (2003) Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 25(1):81–104 Jan

    Article  PubMed  CAS  Google Scholar 

  99. Martin-Kleiner I, Gabrilovac J, Kusec R, Boranic M (2003) Methionine enkephalin suppresses metabolic activity of a leukemic cell line (NALM-1) and enhances CD10 expression. Int Immunopharmacol 3(5):707–711 May

    Article  PubMed  CAS  Google Scholar 

  100. Martin-Kleiner I (2002) The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells. Biomed Pharmacother 56(9):458–462 Nov

    Article  PubMed  CAS  Google Scholar 

  101. Martin-Kleiner I, Gabrilovac J, Boranic M (2004) Opioids as growth regulators of normal and malignant immunohaematopoiesis: a review. Haema 7(3):287–295

    CAS  Google Scholar 

  102. Sibinga Nes, Goldstein A (1988) Opioid peptides and opioid receptors in cells of the immune system. Ann Rev Immunol 6:219–249

    Article  CAS  Google Scholar 

  103. Makman MH (1994) Morphine receptor in immunocytes and neurons. Adv Neuroimmunol 4:69–82

    Article  PubMed  CAS  Google Scholar 

  104. Machelska H, Stein C (2002) Immune mechanisms in pain control. Anesth Analg 95(4):1002–1008 Oct

    Article  PubMed  CAS  Google Scholar 

  105. Brack A, Stein C (2003) The role of the peripheral nervous system in immune cell recruitment. Exp Neurol 184(1):44–49 Nov

    Article  PubMed  CAS  Google Scholar 

  106. Machelska H, Stein C (2000) Pain control by immune-derived opioids. Clin Exp Pharmacol Physiol 27(7):533–536 Jul

    Article  PubMed  CAS  Google Scholar 

  107. Brack A, Rittner HL, Machelska H et al (2004) Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 100(1):149–157 Jan

    Article  PubMed  CAS  Google Scholar 

  108. Sacerdote P, Manfredi B, Mantegazza P, Panerai AE (1997) Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol 121:834–840

    Article  PubMed  CAS  Google Scholar 

  109. Sacerdote P, Bianchi M, Manfredi B, Panerai AE (1997) Effects of tramadol on immune responses and nociceptive thresholds in mice. Pain 72:325–330

    Article  PubMed  CAS  Google Scholar 

  110. Mercadante S, Ferrera P, Villari P, Arcuri E (2003) Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 26(2):769–775

    Article  PubMed  Google Scholar 

  111. Arcuri E (1998) Can tumors act as opioid traps, mimicking opioid tolerance? J Pain Symptom Manage 16(2):78–79 Aug

    Article  PubMed  CAS  Google Scholar 

  112. Arcuri E, Ginobbi P, Tirelli W et al (2002) Preliminary in vivo experimental evidence on intratumoral morphine uptake. Possible clinical implications in cancer pain and opioid responsiveness. J Pain Symptom Manage 24(1):1–3 Jul

    Article  PubMed  Google Scholar 

  113. Fimiani C, Arcuri E, Santoni A et al (1999) Mu3 opiate receptor expression in lung and lung carcinoma: ligand binding and coupling to nitric oxide release. Cancer Lett 146(1):45–51 Nov 1

    Article  PubMed  CAS  Google Scholar 

  114. Furrow BR (2001) Pain management and provider liability: no more excuses. J Law Med Ethics 29:28–51

    Article  PubMed  CAS  Google Scholar 

  115. Arcuri E (2002) A project for a hospital without pain. Med Secoli 14(1):233–241

    PubMed  Google Scholar 

Download references

Acknowledgement

We are indebted to Tommaso Niscola for the provided editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pasquale Niscola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niscola, P., Scaramucci, L., Romani, C. et al. Opioids in pain management of blood-related malignancies. Ann Hematol 85, 489–501 (2006). https://doi.org/10.1007/s00277-005-0062-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-0062-4

Keywords

Navigation